CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.

Source:http://linkedlifedata.com/resource/pubmed/id/19359517

Download in:

View as

General Info

PMID
19359517